BLFS Q2 2025 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$25M+28.9% YoY

Gross Profit

$16M64.6% margin

Operating Income

-$17M-65.5% margin

Net Income

-$16M-62.3% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+6.2%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$6M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$387M

Total Liabilities

$40M

Stockholders' Equity

$347M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$20M	+28.9%
Gross Profit	$16M	$13M	+24.4%
Operating Income	-$17M	-$4M	-354.6%
Net Income	-$16M	-$21M	+23.6%

Revenue Segments

Product

$24M93%

Rental Revenue

$2M7%

Service

$36,0000%